Oral RSV Drug Shows Promise in Early Study Symptoms reduced in volunteers infected with RSV

An oral drug designed to inhibit replication of respiratory syncytial virus (RSV) lowered viral loads and alleviated clinical symptoms in healthy adults who had been inoculated with the virus in an early-stage placebo-controlled trial, researchers said. http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/54773?xid=nl_mpt_DHE_2015-11-19&eun=g721819d0r